Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 13,363 shares at $648.54 ($8.6M) on 2020-07-08, disclosed to the SEC on 2020-07-09.
Open-market sale of $8.6M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $640.88 | 9,321 | $6.0M | 69.8% |
| 2 | $640.88 | 2,019 | $1.3M | 15.1% |
| 3 | $634.14 | 24 | $15K | 0.2% |
| 4 | $636.50 | 585 | $372K | 4.3% |
| 5 | $636.50 | 585 | $372K | 4.3% |
| 6 | $637.40 | 40 |
| $25K |
| 0.3% |
| 7 | $638.99 | 45 | $29K | 0.3% |
| 8 | $639.88 | 80 | $51K | 0.6% |
| 9 | $639.88 | 80 | $51K | 0.6% |
| 10 | $640.32 | 43 | $28K | 0.3% |
| 11 | $642.93 | 48 | $31K | 0.4% |
| 12 | $643.84 | 104 | $67K | 0.8% |
| 13 | $643.84 | 104 | $67K | 0.8% |
| 14 | $645.99 | 57 | $37K | 0.4% |
| 15 | $646.18 | 37 | $24K | 0.3% |
| 16 | $648.54 | 94 | $61K | 0.7% |
| 17 | $648.54 | 94 | $61K | 0.7% |
| 18 | $650.41 | 3 | $2K | 0.0% |
| Total | $640.65 avg | 13,363 | $8.6M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |